{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:15:45Z","timestamp":1783214145901,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009825","name":"American College of Radiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacr.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:53:15Z","timestamp":1773453195000},"page":"1445-1461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ACR Appropriateness Criteria\u00ae Staging and Follow-Up of Pancreatic Neuroendocrine Tumors"],"prefix":"10.1016","volume":"23","author":[{"given":"Joseph H.","family":"Yacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya R.","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks D.","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Chernyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Magnetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena K.","family":"Korngold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2026.02.012_bib1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00261-022-03737-5","article-title":"Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios","volume":"48","author":"Konstantinoff","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jacr.2026.02.012_bib2","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00261-018-1574-4","article-title":"Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance","volume":"43","author":"Lee","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jacr.2026.02.012_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacr.2026.02.012_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacr.2026.02.012_bib5","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1007\/s00330-020-06867-w","article-title":"Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT","volume":"30","author":"Park","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2214\/AJR.11.7058","article-title":"Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors","volume":"199","author":"Balachandran","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2026.02.012_bib7","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.acra.2021.05.017","article-title":"Preoperative prediction of G1 and G2\/3 grades in patients with nonfunctional pancreatic neuroendocrine tumors using multimodality imaging","volume":"29","author":"Liu","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors","volume":"49","author":"Halfdanarson","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.jacr.2026.02.012_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mric.2018.03.010","article-title":"MR imaging of pancreatic neuroendocrine tumors","volume":"26","author":"Lo","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.jacr.2026.02.012_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2214\/AJR.20.23413","article-title":"Tumor size on microscopy, CT, and MRI assessments versus pathologic gross specimen analysis of pancreatic neuroendocrine tumors","volume":"217","author":"Bian","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2026.02.012_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3348\/kjr.2018.0040","article-title":"What is new in the 2017 World Health Organization classification and 8th American Joint Committee on Cancer staging system for pancreatic neuroendocrine neoplasms?","volume":"20","author":"Choe","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib12","first-page":"359","article-title":"Critical updates in neuroendocrine tumors: version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors","volume":"74","author":"Chauhan","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jacr.2026.02.012_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jmri.25756","article-title":"Pancreatic neuroendocrine tumor: correlations between MRI features, tumor biology, and clinical outcome after surgery","volume":"47","author":"Canellas","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jacr.2026.02.012_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","article-title":"NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018","volume":"16","author":"Shah","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jacr.2026.02.012_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa2403991","article-title":"Phase 3 trial of cabozantinib to treat advanced neuroendocrine tumors","volume":"392","author":"Chan","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacr.2026.02.012_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1200\/JCO.22.01013","article-title":"Randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors (ECOG-ACRIN E2211)","volume":"41","author":"Kunz","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacr.2026.02.012_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacr.2026.02.012_bib18","doi-asserted-by":"crossref","first-page":"W283","DOI":"10.2214\/AJR.12.8941","article-title":"Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT","volume":"200","author":"Kawamoto","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2026.02.012_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2214\/AJR.17.18417","article-title":"Prediction of pancreatic neuroendocrine tumor grade based on CT features and texture analysis","volume":"210","author":"Canellas","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2026.02.012_bib20","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00330-021-08316-8","article-title":"Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors","volume":"32","author":"Han","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib21","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00330-014-3317-4","article-title":"Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification","volume":"24","author":"Luo","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib22","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1148\/rg.2020200047","article-title":"Multimodality imaging of abdominopelvic tumors with venous invasion","volume":"40","author":"LeGout","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.jacr.2026.02.012_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacr.2026.02.012_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate Use Criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2026.02.012_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.jacr.2026.02.012_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2967\/jnumed.109.071712","article-title":"68Ga-DOTANOC PET\/CT clinical impact in patients with neuroendocrine tumors","volume":"51","author":"Ambrosini","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2026.02.012_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1148\/radiol.2016160586","article-title":"Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study","volume":"284","author":"Jeon","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2026.02.012_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.pan.2017.05.388","article-title":"Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: a CT and pathology correlation study","volume":"17","author":"Yano","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.jacr.2026.02.012_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00261-013-0011-y","article-title":"Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade","volume":"38","author":"Kim","year":"2013","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jacr.2026.02.012_bib30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ejrad.2015.05.005","article-title":"Pancreatic neuroendocrine tumors: correlation between the contrast-enhanced computed tomography features and the pathological tumor grade","volume":"84","author":"Takumi","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pan.2016.01.002","article-title":"Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection","volume":"16","author":"Arai","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.jacr.2026.02.012_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00261-018-1763-1","article-title":"Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade","volume":"44","author":"Guo","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jacr.2026.02.012_bib33","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s00261-015-0524-7","article-title":"Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade","volume":"40","author":"Pereira","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jacr.2026.02.012_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181bdf8cf","article-title":"Hepatic metastases from neuroendocrine tumors with a \u201cthin slice\u201d pathological examination: they are many more than you think","volume":"251","author":"Elias","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacr.2026.02.012_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.13121628","article-title":"High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging","volume":"268","author":"d\u2019Assignies","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2026.02.012_bib37","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/MPA.0000000000000920","article-title":"Magnetic resonance imaging of neuroendocrine tumor hepatic metastases: does hepatobiliary phase imaging improve lesion conspicuity and interobserver agreement of lesion measurements?","volume":"46","author":"Morse","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.jacr.2026.02.012_bib38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00261-018-1496-1","article-title":"Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent","volume":"43","author":"Tirumani","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jacr.2026.02.012_bib39","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.jacr.2022.02.012","article-title":"ACR Appropriateness Criteria\u00ae staging of colorectal cancer: 2021 update","volume":"19","author":"Korngold","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.crad.2016.05.016","article-title":"Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?","volume":"71","author":"Lavelle","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jacr.2026.02.012_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000326237","article-title":"Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough?","volume":"93","author":"Bhosale","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacr.2026.02.012_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2214\/AJR.21.27159","article-title":"Imaging of neuroendocrine neoplasms: monitoring treatment response-AJR Expert Panel narrative review","volume":"218","author":"Galgano","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2026.02.012_bib43","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1148\/radiol.12120826","article-title":"Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality","volume":"266","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2026.02.012_bib44","series-title":"Measuring sex, gender identity, and sexual orientation","article-title":"Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on National Statistics; Committee on Measuring Sex, Gender Identity, and Sexual Orientation. Measuring sex, gender identity, and sexual orientation","year":"2022"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144026000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144026000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:27:20Z","timestamp":1783211240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144026000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1546144026000724"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2026.02.012","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Staging and Follow-Up of Pancreatic Neuroendocrine Tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}